TRANSCEND-XR is a Horizon Europe-funded research and innovation project (Grant Agreement No. 101214413) uniting 15 partners from 12 countries to transform quality of life for adolescent and young adult testicular cancer survivors. The consortium, including leading universities, hospitals, XR technology specialists, and advocacy networks, co-creates advanced extended reality solutions that inform, empower, and deliver personalised post-treatment support.
Through this collaborative approach, survivors, families, healthcare professionals, and policy makers access state-of-the-art resources and engage with the latest digital innovations in cancer care - setting new standards for survivorship across Europe.
FundtoInnovate leads all impact, dissemination, and exploitation activities for TRANSCEND-XR. As Impact Lead, FundtoInnovate:
Stay up to date with the latest milestones: transcend-xr.eu.
Connect with our team, join the conversation, or follow TRANSCEND-XR developments:
Visit the official project website: transcend-xr.eu
Follow FundtoInnovate’s updates across social media
Reach out to enquire about partnership, collaboration, or cluster participation